UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database
Study Type – Therapy (outcomes) Level of Evidence 2b What’s known on the subject? and What does the study add? A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes. This large scale pro...
        Saved in:
      
    
          | Published in | BJU international Vol. 109; no. 3; pp. 346 - 354 | 
|---|---|
| Main Authors | , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Oxford, UK
          Blackwell Publishing Ltd
    
        01.02.2012
     Wiley-Blackwell Wiley Subscription Services, Inc  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1464-4096 1464-410X 1464-410X  | 
| DOI | 10.1111/j.1464-410X.2011.10334.x | 
Cover
| Abstract | Study Type – Therapy (outcomes)
Level of Evidence 2b
What’s known on the subject? and What does the study add?
A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes.
This large scale prospective British Radical Prostatectomy study adds weight to this increasing body of evidence by supporting the hypothesis and also in raising the suggestion that current UK guidelines with respect to minimum surgeon case volume be significantly increased.
OBJECTIVE
• To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon.
MATERIALS AND METHODS
• All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009.
• Patient age, prostate‐specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume.
• The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence.
RESULTS
• A total of 8032 RP cases were entered on the database and Follow‐up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL.
• Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219.
• The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre‐operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P  <  0.01).
• When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8–10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis.
• Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum.
CONCLUSIONS
• High volume surgeons have less peri‐operative and postoperative complications and better surgical and disease‐free outcomes than low volume surgeons.
• In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes. | 
    
|---|---|
| AbstractList | To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon.
All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence.
A total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P < 0.01). When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum.
High volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes. Study Type – Therapy (outcomes) Level of Evidence 2b What’s known on the subject? and What does the study add? A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes. This large scale prospective British Radical Prostatectomy study adds weight to this increasing body of evidence by supporting the hypothesis and also in raising the suggestion that current UK guidelines with respect to minimum surgeon case volume be significantly increased. OBJECTIVE • To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon. MATERIALS AND METHODS • All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. • Patient age, prostate‐specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. • The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence. RESULTS • A total of 8032 RP cases were entered on the database and Follow‐up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. • Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. • The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre‐operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P < 0.01). • When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8–10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. • Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum. CONCLUSIONS • High volume surgeons have less peri‐operative and postoperative complications and better surgical and disease‐free outcomes than low volume surgeons. • In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes. To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon.OBJECTIVETo undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon.All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence.MATERIALS AND METHODSAll RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence.A total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P < 0.01). When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum.RESULTSA total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3 ng/mL. Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P < 0.01). When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum.High volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes.CONCLUSIONSHigh volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes. Study Type - Therapy (outcomes) Level of Evidence2b What's known on the subject? and What does the study add? A slowly emerging body of urological outcome data reports lends increasing credence to the intuitive hypothesis that high volume surgeons have better surgical outcomes. This large scale prospective British Radical Prostatectomy study adds weight to this increasing body of evidence by supporting the hypothesis and also in raising the suggestion that current UK guidelines with respect to minimum surgeon case volume be significantly increased. OBJECTIVE *To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes of radical prostatectomy (RP) with particular reference to the case volume of the operating surgeon. MATERIALS AND METHODS *All RP entries on the BAUS complex operations database were extracted from its commencement in January 2004 to September 2009. *Patient age, prostate-specific antigen (PSA) levels, clinical tumour stage and biopsy Gleason score were analyzed together with operative variables, including the surgical approach, lymphadenectomy status, blood loss, hospital length of stay and individual surgeon case volume. *The postoperative variables assessed included surgical specimen Gleason score and pathological tumour stage, prostate weight and the presence of positive surgical margins (PSM), as well as evidence of biochemical recurrence. RESULTS *A total of 8032 RP cases were entered on the database and Follow-up data was available on 4206 cases. Mean patient age was 61.8 years and the mean presenting PSA was 8.3ng/mL. *Open RP procedures were performed on 5429 patients and laparoscopic RP on 2219. *The positive surgical margin (PSM) rate for the entire series was 38%. Analysis of PSM by pathological stage revealed a pT2 PSM rate of 24%. Multivariate analysis of variables which might affect PSM revealed pre-operative clinical TNM stage, surgeon case volume, RP specimen Gleason score and pathological TNM stage were significant parameters (P< 0.01). *When prostate weight and PSM status were analysed, these was a significant association between smaller prostate weight and PSM status. Interestingly, 45% of high grade Gleason 8-10 needle biopsy cancers were downgraded to Gleason scores 7 or less on RP analysis. *Analysis of annual surgeon caseload revealed that 54% of surgeons performed an average of less than 10 procedures per annum and 6% of surgeons performed an average of 30 or more procedures per annum. When individual outcome variables where examined against surgeon case activity it was demonstrated that outcomes are clearly improved beyond 20 cases and there is a trend to continued improvement up to the series maximum of 40 cases per annum. CONCLUSIONS *High volume surgeons have less peri-operative and postoperative complications and better surgical and disease-free outcomes than low volume surgeons. *In the UK, raising the current minimum Improving Outcomes Guidance threshold from five RP cases per surgeon per annum to no less than 20 (and ideally to 35 or more cases per annum) could potentially improve overall outcomes. [PUBLICATION ABSTRACT]  | 
    
| Author | Hounsome, Luke McCabe, John E. Fowler, Sarah Vesey, Sean G.  | 
    
| Author_xml | – sequence: 1 givenname: Sean G. surname: Vesey fullname: Vesey, Sean G. – sequence: 2 givenname: John E. surname: McCabe fullname: McCabe, John E. – sequence: 3 givenname: Luke surname: Hounsome fullname: Hounsome, Luke – sequence: 4 givenname: Sarah surname: Fowler fullname: Fowler, Sarah  | 
    
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25461866$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21771246$$D View this record in MEDLINE/PubMed  | 
    
| BookMark | eNqVkttuEzEQhleoiB7gFZAlhLjK4rHXe-ACqQ1nKvWCRuLOmjhO62h3HTxeSB6Gd8WbpEXqFViWPB5_MyP_M6fZUe97m2UMeA5pvV7lUJTFpAD-PRccIAcuZZFvHmUn9w9HdzZvyuPslGjFeXKU6kl2LKCqQBTlSfZ79pUFXDiDLVsHTxGjNdF3W-aHaHxniWG_YDSEG-t7ZpAs--nbobNv2DxdFix5cdzYbskR80sWby27CC46umXnRN44jC5h6WkWfOtvdtW-7VMSm_pu3doNu1rbsAOJvcOIY_an2eMltmSfHc6z7PrD--vpp8nl1cfP0_PLiSlEVUwWBrEysrTAoURlBCgFVSlqqKuqEWKpQEqJjeBzgUmBQqIFUDUKEPN5I8-yV_u0SYEfg6WoO0fGti321g-kGygV1KouEvniAbnyQ0h_Jw1SSalEU_NEPT9Qw7yzC70OrsOw1XeyJ-DlAUBKWiwD9sbRX04VJdTlyNV7zqTWULDLewS4HidBr_TYZD02XI-ToHeToDcp9O2DUOPiTt4Y0LX_keCXa-32nwvriy-znSn_AODTzRk | 
    
| CODEN | BJINFO | 
    
| CitedBy_id | crossref_primary_10_1111_bju_12866 crossref_primary_10_1111_bju_15516 crossref_primary_10_1186_s12894_019_0526_9 crossref_primary_10_1111_bju_15656 crossref_primary_10_1111_bju_14687 crossref_primary_10_1007_s00345_015_1540_5 crossref_primary_10_1111_bju_14541 crossref_primary_10_1097_SLA_0000000000000852 crossref_primary_10_1186_1471_2490_14_82 crossref_primary_10_1016_j_eururo_2013_04_012 crossref_primary_10_1002_nau_24143 crossref_primary_10_1186_1471_2490_14_86 crossref_primary_10_2217_fon_13_3 crossref_primary_10_1016_j_juro_2011_12_080 crossref_primary_10_1016_j_eururo_2021_04_028 crossref_primary_10_1007_s00120_020_01321_7 crossref_primary_10_1177_1756287212447092 crossref_primary_10_1038_bjc_2013_589 crossref_primary_10_1016_j_urolonc_2016_09_003 crossref_primary_10_1016_j_euf_2017_03_008 crossref_primary_10_1016_j_eururo_2013_11_018 crossref_primary_10_1007_s13629_013_0003_2 crossref_primary_10_1177_2051415816664272 crossref_primary_10_1016_j_fertnstert_2018_03_020 crossref_primary_10_3109_00365599_2012_707684 crossref_primary_10_1016_j_urology_2015_11_026 crossref_primary_10_1016_j_urolonc_2019_01_006 crossref_primary_10_1097_MOP_0000000000000214 crossref_primary_10_5301_uro_5000125 crossref_primary_10_1111_j_1464_410X_2012_11367_x crossref_primary_10_1007_s11701_022_01517_3 crossref_primary_10_1016_j_clon_2016_02_004 crossref_primary_10_1016_j_urolonc_2017_02_007 crossref_primary_10_1186_s13014_022_02046_x crossref_primary_10_1177_20514158211063964  | 
    
| Cites_doi | 10.1016/j.eururo.2006.02.051 10.1111/j.1464-410X.2007.07118.x 10.1016/j.eururo.2009.01.036 10.1111/j.1464-410X.2005.05717.x 10.1016/j.urolonc.2005.11.039 10.1136/bmj.c1128 10.1016/j.juro.2008.01.107 10.1016/S0022-5347(05)65177-4 10.1016/j.juro.2006.04.048 10.1016/S0022-5347(05)64670-8 10.1056/NEJMsa035205 10.1016/j.juro.2010.08.003 10.1097/01.ju.0000169475.00949.78 10.1016/j.urolonc.2009.07.014 10.1016/j.urolonc.2009.03.001 10.1111/j.1464-410X.2005.05245.x 10.1016/j.eururo.2008.12.001 10.1046/j.1464-410X.1996.00619.x 10.3109/00365590902916930 10.1111/j.1464-410X.2008.08169.x  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL 2015 INIST-CNRS 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.  | 
    
| Copyright_xml | – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL – notice: 2015 INIST-CNRS – notice: 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.  | 
    
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8  | 
    
| DOI | 10.1111/j.1464-410X.2011.10334.x | 
    
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts MEDLINE - Academic  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Calcium & Calcified Tissue Abstracts MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE MEDLINE - Academic Calcium & Calcified Tissue Abstracts  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1464-410X | 
    
| EndPage | 354 | 
    
| ExternalDocumentID | 2975470011 21771246 25461866 10_1111_j_1464_410X_2011_10334_x BJU10334  | 
    
| Genre | article Journal Article  | 
    
| GeographicLocations | United Kingdom Europe  | 
    
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HF~ HGLYW HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY AIQQE CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8  | 
    
| ID | FETCH-LOGICAL-c4274-dcaa7c36e1016a5c2155176281877922f51333a920b2a66543ae1158a212bb93 | 
    
| IEDL.DBID | DR2 | 
    
| ISSN | 1464-4096 1464-410X  | 
    
| IngestDate | Thu Oct 02 21:05:24 EDT 2025 Tue Oct 07 06:23:47 EDT 2025 Wed Feb 19 01:58:00 EST 2025 Mon Jul 21 09:14:16 EDT 2025 Thu Apr 24 23:07:20 EDT 2025 Wed Oct 01 04:28:49 EDT 2025 Wed Jan 22 16:48:15 EST 2025  | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 3 | 
    
| Keywords | Nephrology Prognosis Prostate disease Size Operation Urinary tract Urology prostate size Association radical prostatectomy Surgery Database Urogenital system Male genital diseases outcome Urinary system disease Malignant tumor Complexes Surgeon surgeon volume Treatment Urinary system Volume Prostatectomy Prostate cancer Prostate Cancer  | 
    
| Language | English | 
    
| License | CC BY 4.0 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.  | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c4274-dcaa7c36e1016a5c2155176281877922f51333a920b2a66543ae1158a212bb93 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23  | 
    
| PMID | 21771246 | 
    
| PQID | 1353352980 | 
    
| PQPubID | 1026371 | 
    
| PageCount | 9 | 
    
| ParticipantIDs | proquest_miscellaneous_916518584 proquest_journals_1353352980 pubmed_primary_21771246 pascalfrancis_primary_25461866 crossref_primary_10_1111_j_1464_410X_2011_10334_x crossref_citationtrail_10_1111_j_1464_410X_2011_10334_x wiley_primary_10_1111_j_1464_410X_2011_10334_x_BJU10334  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | February 2012 | 
    
| PublicationDateYYYYMMDD | 2012-02-01 | 
    
| PublicationDate_xml | – month: 02 year: 2012 text: February 2012  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | Oxford, UK | 
    
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England – name: Edgecliff  | 
    
| PublicationTitle | BJU international | 
    
| PublicationTitleAlternate | BJU Int | 
    
| PublicationYear | 2012 | 
    
| Publisher | Blackwell Publishing Ltd Wiley-Blackwell Wiley Subscription Services, Inc  | 
    
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley-Blackwell – name: Wiley Subscription Services, Inc  | 
    
| References | 2009; 56 2009; 55 2003; 349 2005; 174 2006; 50 2009; 43 2006; 24 2010; 28 2002; 168 2007; 100 2002; 167 2005; 95 2005; 96 2006; 176 2010; 340 2010; 184 2008; 179 2009; 103 1996; 78 e_1_2_8_23_2 e_1_2_8_24_2 e_1_2_8_25_2 e_1_2_8_26_2 e_1_2_8_9_2 e_1_2_8_2_2 e_1_2_8_4_2 e_1_2_8_3_2 e_1_2_8_6_2 e_1_2_8_5_2 e_1_2_8_8_2 e_1_2_8_7_2 e_1_2_8_20_2 e_1_2_8_21_2 e_1_2_8_22_2 e_1_2_8_16_2 e_1_2_8_17_2 e_1_2_8_18_2 e_1_2_8_19_2 e_1_2_8_12_2 e_1_2_8_13_2 e_1_2_8_14_2 e_1_2_8_15_2 e_1_2_8_10_2 e_1_2_8_11_2  | 
    
| References_xml | – volume: 168 start-page: 514 year: 2002 end-page: 8 article-title: Is a limited lymph node dissection an adequate staging procedure for prostate cancer? publication-title: J Urol – volume: 176 start-page: 991 year: 2006 end-page: 5 article-title: Poorly differentiated prostate cancer treated with radical prostatectomy: long‐term outcome and incidence of pathological downgrading publication-title: J Urol – volume: 28 start-page: 219 year: 2010 end-page: 25 article-title: Radical prostatectomy: does surgical technique influence margin control? publication-title: Urol Oncol – volume: 95 start-page: 34 year: 2005 end-page: 9 article-title: Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time publication-title: BJU Int – volume: 24 start-page: 465 year: 2006 end-page: 71 article-title: Survival results in patients with screen‐detected prostate cancer versus physician‐referred patients treated with radical prostatectomy: early results publication-title: Urol Oncol – volume: 96 start-page: 806 year: 2005 end-page: 10 article-title: Defining the minimum hospital case‐ load to achieve optimum outcomes in radical cystectomy publication-title: BJU Int – volume: 43 start-page: 350 year: 2009 end-page: 6 article-title: Nationwide population‐based study on 30‐day mortality after radical prostatectomy in Sweden publication-title: Scand J Urol Nephrol – volume: 55 start-page: 1037 year: 2009 end-page: 63 article-title: Retropubic, laparoscopic, and robot‐assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies publication-title: Eur Urol – volume: 174 start-page: 903 year: 2005 end-page: 7 article-title: Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens publication-title: J Urol – volume: 100 start-page: 1040 year: 2007 end-page: 9 article-title: Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of hospital episodes statistics for England publication-title: BJU Int – volume: 28 start-page: 243 year: 2010 end-page: 50 article-title: Impact of surgeon and hospital volume on outcomes of radical prostatectomy publication-title: Urol Oncol – volume: 179 start-page: 2212 year: 2008 end-page: 6 article-title: Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories publication-title: J Urol – volume: 78 start-page: 911 year: 1996 end-page: 8 article-title: A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome publication-title: Br J Urol – volume: 50 start-page: 98 year: 2006 end-page: 104 article-title: Intra‐ and peri‐operative outcomes comparing radical retropubic and laparoscopic radical prostatectomy: results from a prospective, randomised, single‐surgeon study publication-title: Eur Urol – volume: 340 start-page: c1128 year: 2010 article-title: The volume‐mortality relation for radical cystectomy in England: retrospective analysis of hospital episode statistics publication-title: BMJ – volume: 184 start-page: 2291 year: 2010 end-page: 6 article-title: The learning curve for laparoscopic radical prostatectomy: an international multicenter study publication-title: J Urol – volume: 167 start-page: 1681 year: 2002 end-page: 6 article-title: Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis publication-title: J Urol – volume: 56 start-page: 651 year: 2009 end-page: 7 article-title: Reducing laparoscopic radical prostatectomy false‐positive margin rates using cyanoacrylate tissue glue publication-title: Eur Urol – volume: 103 start-page: 1224 year: 2009 end-page: 30 article-title: The first 1000 cases of laparoscopic radical prostatectomy in the UK: evidence of multiple ‘learning curves’ publication-title: BJU Int – volume: 349 start-page: 2117 year: 2003 end-page: 27 article-title: Surgeon volume and operative mortality in the United States publication-title: N Engl J Med – ident: e_1_2_8_2_2 – ident: e_1_2_8_5_2 – ident: e_1_2_8_14_2 doi: 10.1016/j.eururo.2006.02.051 – ident: e_1_2_8_6_2 doi: 10.1111/j.1464-410X.2007.07118.x – ident: e_1_2_8_10_2 doi: 10.1016/j.eururo.2009.01.036 – ident: e_1_2_8_18_2 doi: 10.1111/j.1464-410X.2005.05717.x – ident: e_1_2_8_13_2 doi: 10.1016/j.urolonc.2005.11.039 – ident: e_1_2_8_19_2 doi: 10.1136/bmj.c1128 – ident: e_1_2_8_16_2 doi: 10.1016/j.juro.2008.01.107 – ident: e_1_2_8_23_2 doi: 10.1016/S0022-5347(05)65177-4 – ident: e_1_2_8_25_2 doi: 10.1016/j.juro.2006.04.048 – ident: e_1_2_8_24_2 doi: 10.1016/S0022-5347(05)64670-8 – ident: e_1_2_8_15_2 doi: 10.1056/NEJMsa035205 – ident: e_1_2_8_21_2 doi: 10.1016/j.juro.2010.08.003 – ident: e_1_2_8_12_2 doi: 10.1097/01.ju.0000169475.00949.78 – ident: e_1_2_8_9_2 doi: 10.1016/j.urolonc.2009.07.014 – ident: e_1_2_8_3_2 – ident: e_1_2_8_17_2 doi: 10.1016/j.urolonc.2009.03.001 – ident: e_1_2_8_11_2 doi: 10.1111/j.1464-410X.2005.05245.x – ident: e_1_2_8_22_2 – ident: e_1_2_8_26_2 doi: 10.1016/j.eururo.2008.12.001 – ident: e_1_2_8_7_2 doi: 10.1046/j.1464-410X.1996.00619.x – ident: e_1_2_8_4_2 – ident: e_1_2_8_20_2 doi: 10.3109/00365590902916930 – ident: e_1_2_8_8_2 doi: 10.1111/j.1464-410X.2008.08169.x  | 
    
| SSID | ssj0014665 | 
    
| Score | 2.201463 | 
    
| Snippet | Study Type – Therapy (outcomes)
Level of Evidence 2b
What’s known on the subject? and What does the study add?
A slowly emerging body of urological outcome... To undertake a detailed analysis of the British Association of Urological Surgeons (BAUS) Section of Oncology Complex Operations Database to report UK outcomes... Study Type - Therapy (outcomes) Level of Evidence2b What's known on the subject? and What does the study add? A slowly emerging body of urological outcome data...  | 
    
| SourceID | proquest pubmed pascalfrancis crossref wiley  | 
    
| SourceType | Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 346 | 
    
| SubjectTerms | Adult Aged Aged, 80 and over Biological and medical sciences Blood Loss, Surgical - statistics & numerical data Clinical Competence - standards Gynecology. Andrology. Obstetrics Humans Hypotheses Length of Stay Lymph Node Excision - standards Lymph Node Excision - statistics & numerical data Lymphatic Metastasis Male Male genital diseases Medical sciences Middle Aged Multivariate analysis Neoplasm Grading Nephrology. Urinary tract diseases Organ Size outcome Prostate cancer prostate size Prostate-Specific Antigen - blood Prostatectomy - standards Prostatectomy - statistics & numerical data Prostatic Neoplasms - pathology Prostatic Neoplasms - surgery radical prostatectomy surgeon volume Tumors Tumors of the urinary system United Kingdom Urinary tract. Prostate gland Urology - standards Urology - statistics & numerical data Workload - statistics & numerical data  | 
    
| Title | UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database | 
    
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2011.10334.x https://www.ncbi.nlm.nih.gov/pubmed/21771246 https://www.proquest.com/docview/1353352980 https://www.proquest.com/docview/916518584  | 
    
| Volume | 109 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1464-410X dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0014665 issn: 1464-4096 databaseCode: ABDBF dateStart: 19990101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1464-410X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014665 issn: 1464-4096 databaseCode: DIK dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1464-4096 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1464-410X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014665 providerName: Wiley-Blackwell  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh1IofT_cpmEOvXpZW1p71VtfIaSkhTYLexMjrXxJai9rL6T5L_mvnZG8bh1yCKXgg7E8Y1sezXx6fSPE27xSlSUYndqs0KlCj6mlW9O5LZzUyqF1PA558rU4Wqjj5WzZr3_ivTCRH2IYcOOWEfw1N3C07fVGrlKVTZeRiTObSqkmjCczWYTe1feBSYpuDVklowjB9vGinhsVjSLV_TW2VGlVzHZxExwdo9sQng4firPdh8VVKWeTbWcn7vIa5-P_-fJH4kGPYuF9NLvH4o6vn4i7J_08_VNxtfgCGwxTQLDmfSXIcxXNz1_QbDt6nG8B6xW0vCe7qcFRKIXoJ98Bx9UV0FXkI1KmQFMBIVXoKZjgL6PiosVm58LhR1TZAju6c38B39Y-GnkLn7BD1v5MnB5-Pv14lPaJIFKnqNecrhxi6WTheagBZy5nnEdenMBGWeo8rzhJjUSdT22OnE5ZoiekO0eKy9Zq-Vzs1U3tXwrQ1N-tCq0Kr8OeY7RKzbyvJJbeE7RLRLn758b1JOmcq-PcjDpLynDlG658EyrfXCQiGyTXkSjkFjIHI7MaBDlJATMRJmJ_Z2em9y2t4UwlBJv1fJoIGIrJK_BUD9a-2baGQP-MkNhcJeJFNM8_urOyJFBHustgZLd-W_PheBFOX_2z5Gtxj67ncdX7vtjrNlv_hkBdZw9Cc_0NNPM9Ow | 
    
| linkProvider | Wiley-Blackwell | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hIgFSxRtqKGUOXB35sbFjbkCpQtsUCRIpt9XsZn0h2FHsSG3_S_9rZ7yOwVUPFULywbJ3xvZ6dubb1zdCfIhymWuC0b4Ok8yXaNHXVNQf6cTEmTSoDY9DTs6S8Uwez4fzNh0Q74Vx_BDdgBu3jMZfcwPnAembrVz6MgzmjoozDOJYDghQ3qfrAZv44Y-OS4rKNnklnQwB9_6ynls19WLV7gorqrbc5bu4DZD28W0ToI6eiOX209y6lF-DTa0H5vIG6-N_-van4nELZOGTs7xn4p4tnosHk3aq_oW4mp3AGptZIFjx1hLk6Yry9wWUm5qeZyvAYgEVb8suCzAUTcG5yo_AoXUBdBX5cKwpUOZAYBVaFib4y6741my99eLw06msgH3d0p7D95V1dl7BIdbI2l-K6dHX6Zex3-aC8I2kjrO_MIipiRPLow04NBFDPXLkhDfSNIuinPPUxJhFgY6QMyrHaAnsjpBCs9ZZ_ErsFGVh9wRk1OXNk0wmNmu2HaOWcmhtHmNqLaE7T6Tbn65My5PO6TqWqtdfkoorX3Hlq6by1bknwk5y5bhC7iBz0LOrTpDzFDAZoSf2t4amWvdSKU5WQsg5GwWegO42OQae7cHClptKEe4fEhgbSU-8dvb5R3eYpoTrSHfaWNmd31Z9Pp41p2_-WfK9eDieTk7V6bezk7fiEZWJ3CL4fbFTrzf2HWG8Wh80bfcaF4RBXA | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQkSokxPsRKGUOXLPaJM7D3IBlVVpaEHSlvVnjrHNhSaJNVir8F_4rM3E2kKqHCiHlECWeSeKMZz6_vhHiVVjIwhCM9k2QKF-iRd9QUT8zSR4pmaPJeRzy9Cw5WsjjZbzs0wHxXhjHDzEMuHHL6Pw1N3Bbr4rLrVz6MpguHRVnMI0iOSFAeVPGKuP1fbMvA5cUle3ySjoZAu7jZT1XahrFqts1NlRthct3cRUgHePbLkDN74r17tPcupRvk21rJvnPS6yP_-nb74k7PZCFN87y7osbtnwg9k_7qfqH4tfiBDbYzQJBzVtLkKcrqu8_oNq29DzbAJYraHhbdlVCTtEUnKt8DRxaV0BXkQ_HmgJVAQRWoWdhgr_sim8tNjsvDl-dygbY163tBXyqrbPzBmbYImt_JM7n78_fHfl9Lgg_l9Rx9lc5YppHieXRBozzkKEeOXLCG2mqwrDgPDURqnBqQuSMyhFaArsZUmg2RkWPxV5ZlfapAEVd3iJRMrGq23aMRsrY2iLC1FpCd55Idz9d5z1POqfrWOtRf0lqrnzNla-7ytcXnggGydpxhVxD5nBkV4Mg5ylgMkJPHOwMTffupdGcrISQs8qmnoDhNjkGnu3B0lbbRhPujwmMZdITT5x9_tEdpCnhOtKddlZ27bfVb48X3emzf5Z8KfY_z-b644ezk-fiFhUJ3Rr4A7HXbrb2BUG81hx2Tfc3ZR9A4A | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=UK+radical+prostatectomy+outcomes+and+surgeon+case+volume%3A+based+on+an+analysis+of+the+British+Association+of+Urological+Surgeons+Complex+Operations+Database&rft.jtitle=BJU+international&rft.au=Vesey%2C+Sean+G&rft.au=McCabe%2C+John+E&rft.au=Hounsome%2C+Luke&rft.au=Fowler%2C+Sarah&rft.date=2012-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=109&rft.issue=3&rft.spage=346&rft_id=info:doi/10.1111%2Fj.1464-410X.2011.10334.x&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2975470011 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon |